Follow-The-Filings

Security · featured owners

COGT Cogent Biosciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • $658K

COGT (Cogent Biosciences Inc.) is held in 1 featured 13F book as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management 2026 Q2 <0.01% Hold 17,000 $658K history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
424B5 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Aug 27, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 9, 2026 · 6 forms Filing Doc
4 Period May 19, 2026 Filing Doc
4 Period Apr 1, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Jan 22, 2026 Filing Doc
4 Period Jan 1, 2026 Filing Doc
4 Period Dec 26, 2025 · 4 forms Filing Doc
4 Period Dec 17, 2025 · 6 forms Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$192.41M -$255.86M -$328.94M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $270.77M $296.47M $910.36M
Total non-current assets * $42.67M $31.43M $27.25M
Total assets $313.44M $327.9M $937.61M
Total current liabilities $38.17M $55.71M $63.95M
Total non-current liabilities * $17.47M $15.9M $237.28M
Total equity $257.8M $256.29M $636.37M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$153.62M -$207.79M -$264.44M
Cash from investing -$97.82M $38.28M -$399.53M
Cash from financing $163.54M $214.45M $878.23M
Net change in cash -$87.91M $44.94M $214.26M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders